1.41
Cocrystal Pharma Inc stock is traded at $1.41, with a volume of 22,689.
It is up +2.17% in the last 24 hours and down -6.00% over the past month.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
See More
Previous Close:
$1.38
Open:
$1.4
24h Volume:
22,689
Relative Volume:
0.01
Market Cap:
$19.58M
Revenue:
-
Net Income/Loss:
$-8.83M
P/E Ratio:
-1.7835
EPS:
-0.7906
Net Cash Flow:
$-8.61M
1W Performance:
+1.44%
1M Performance:
-6.00%
6M Performance:
+39.60%
1Y Performance:
-4.41%
Cocrystal Pharma Inc Stock (COCP) Company Profile
Name
Cocrystal Pharma Inc
Sector
Industry
Phone
(786) 459-1831
Address
19805 N. CREEK PARKWAY, BOTHELL, WA
Compare COCP vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
COCP
Cocrystal Pharma Inc
|
1.42 | 19.02M | 0 | -8.83M | -8.61M | -0.7906 |
|
VRTX
Vertex Pharmaceuticals Inc
|
428.25 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
|
REGN
Regeneron Pharmaceuticals Inc
|
720.03 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
811.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
304.18 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
315.00 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-20 | Initiated | H.C. Wainwright | Buy |
Cocrystal Pharma Inc Stock (COCP) Latest News
[EFFECT] Cocrystal Pharma, Inc. SEC Filing - Stock Titan
Cocrystal Showcases Norovirus Candidate CDI-988 at ICAR 2026 - TipRanks
Cocrystal Pharma (COCP) advances Fast Track CDI-988 in Phase 1b norovirus challenge study - Stock Titan
No approved norovirus drugs; Cocrystal tests oral CDI-988 - Stock Titan
COCP stock soars 75% — what is the link to Cocrystal’s norovirus treatment? - MSN
Cocrystal Pharma Incfiles to offer up to $150 million in securitiesSEC filing - marketscreener.com
Cocrystal Pharma (NASDAQ: COCP) files $150M shelf to offer stock and warrants - Stock Titan
COCP: Q4 2025 Earnings: Cocrystal Pharma Inc. posts 4.8% EPS beat with no Q4 revenueTop Analyst Buy Signals - Cổng thông tin điện tử tỉnh Tây Ninh
Cocrystal (COCP) Stock: Why Efficiency Gains (Momentum Building) 2026-04-22RSI Oversold Stocks - Xã Vĩnh Công
Why Cocrystal Pharma Shares Are Cooling Off Monday? - MSN
Form 8-KCurrent report - ADVFN
Cocrystal Pharma (COCP) price target increased by 33.33% to 8.16 - MSN
Smart Money: Can Cocrystal Pharma Inc deliver consistent EPS growth2026 Technical Patterns & Daily Growth Stock Tips - baoquankhu1.vn
Investor Mood: Is Cocrystal Pharma Inc benefiting from innovation trendsQuarterly Risk Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
What events could move Cocrystal (COCP) Stock next | Price at $1.29, Down 9.79%Crowd Trend Signals - Newser
Tech Rally: Is Cocrystal Pharma Inc stock risky to hold nowMarket Activity Summary & Consistent Profit Trading Strategies - baoquankhu1.vn
COCP: Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Prevention - Zacks Small Cap Research
Is Cocrystal (COCP) Stock Cheap at Current Price | Price at $1.47, Down 2.00%Support Bounce - Newser
Cocrystal Pharma, Inc. (COCP) stock price, news, quote and history - Yahoo Finance UK
COCP PE Ratio & Valuation, Is COCP Overvalued - Intellectia AI
We're Keeping An Eye On Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Rate - Yahoo Finance
Shares +48% after hours: COCP Cocrystal Pharma NASDAQ 03 Apr earnings spotlight - meyka.com
12 Health Care Stocks Moving In Thursday's Intraday Session - Sahm
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
Crude Oil Rises Sharply; Acuity Shares Fall After Q2 Results - Sahm
Nasdaq Down 1%; US Initial Jobless Claims Fall - Sahm
Cocrystal Pharma Shares Soar After FDA Grants Fast Track Status To CDI-988 - Sahm
COCP Stock Analysis: Cocrystal Pharma Inc. biotech stock surges 48 percent to 1.51 level - Xã Vĩnh Công
FDA grants fast track status to Cocrystal’s norovirus drug By Investing.com - Investing.com Australia
Cocrystal Pharma stock surges on FDA Fast Track designation By Investing.com - Investing.com Canada
Cocrystal Pharma (COCP) Receives FDA Fast Track Status for Norov - GuruFocus
Cocrystal Pharma stock surges on FDA Fast Track designation - Investing.com
Cocrystal Pharma, Inc. (8CC.F) stock price, news, quote and history - Yahoo Finance UK
Cocrystal Pharma Advances in Norovirus Study as Financial Challenges Loom - StocksToTrade
Cocrystal Pharma Wins FDA Fast Track for Norovirus Drug - TipRanks
COCP Stock Soars 75% — What Is The Link To Cocrystal’s Norovirus Treatment? - Stocktwits
Cocrystal Pharma Advances Antiviral Trials Amid Financial Strategy Shift - timothysykes.com
FDA grants fast track status to Cocrystal’s norovirus drug - Investing.com
FDA Fast Track backs Cocrystal (Nasdaq: COCP) oral norovirus antiviral CDI-988 - Stock Titan
Cocrystal Pharma Inc Stock (COCP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cocrystal Pharma Inc Stock (COCP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | Director |
Feb 06 '26 |
Buy |
0.95 |
50,000 |
47,280 |
1,888,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 31 '25 |
Buy |
0.95 |
50,000 |
47,275 |
1,838,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 30 '25 |
Buy |
0.97 |
20,000 |
19,310 |
1,788,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 26 '25 |
Buy |
0.97 |
40,000 |
38,944 |
1,768,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 24 '25 |
Buy |
0.97 |
25,000 |
24,258 |
1,728,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 26 '25 |
Buy |
0.99 |
4,000 |
3,975 |
1,703,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 25 '25 |
Buy |
0.94 |
20,000 |
18,812 |
1,699,551 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):